About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global Expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information ESG Contact us
Products Services
Product center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Career
Talent R&D Team Employee Life Job Opportunities
EN
CN
About Us
· Company Introduction · Strategic Development · Social Responsibility
Scientific Research
· Innovative Layout · Innovative Field
Products Services
· Product center · Product branding · Quality & Safety
News
· Company News · Media Coverage · Media Inquiries · Multimedia zone
Vocational
· Concept about Talent · R&D Team · Employee Life · Job Opportunities
> News > Company
Return
Grand Pharma Presents at the 2024 Annual National Rhinology Conference
2024-09-04

Recently, the 2024 National Rhinology Annual Conference and the 15th Symposium on Nasal Infections and Allergic Diseases, which was organized by the Chinese Medical Journal and co-sponsored by the Chinese Journal of Otolaryngology, Head and Neck Surgery of the Chinese Medical Association, the Chinese Branch of Otolaryngology and the World Journal of Otolaryngology, Head and Neck Surgery, was held in Changchun City, Jilin Province, China.

During the exhibition, Grand Pharma brought several of its subsidiaries to the booth, mainly displaying rhinology products. Grand Pharma’s rhinology products are used in outpatient and perioperative rhinology treatment and daily care to protect nasal health.

Prev

Next

Related news

  • The NDA of Grand Pharma’s Global Innovative RDC TLX591-CDx Is Accepted by the NMPA
    The NDA of Grand Pharma’s Global Innovative RDC TLX591-CDx Is Accepted by the NMPA

    2026-01-19

  • Grand Pharma 2025 Annual Highlights Review
    Grand Pharma 2025 Annual Highlights Review

    2026-01-26

  • Grand Pharma’s Subsidiary Has Entered Into a Share Purchase Agreement to Acquire All Equity of Hebei Yuanda Jiufu Biotechnology Co., Ltd. and Baoding Jiahe Fine Chemical Co., Ltd.
    Grand Pharma’s Subsidiary Has Entered Into a Share Purchase Agreement to Acquire All Equity of Hebei Yuanda Jiufu Biotechnology Co., Ltd. and Baoding Jiahe Fine Chemical Co., Ltd.

    2026-01-04

Grand Pharma Group
About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information Contact us
Products Services
Product Center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Vocational
Concept about Talent R&D Team Employee Life Job Opportunities
Copyright © Grand Pharma (China) Co., Ltd. All Rights Reserved E ICP B 10008288 EGWAB 42010402000597
Legal Provisions